Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults [Phase 2]

View source ↗

Summary

Clinical trial update notes a Phase 2 study evaluating IPN10200 for cervical dystonia in adults. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPN10200

Snippet

Sponsor: Ipsen | Conditions: Cervical Dystonia | Phase 2 | Status: RECRUITING